/PAC1:

Tayla A Rees1, Alejandro Labastida-Ramírez2, Eloisa Rubio-Beltrán2

  • 1School of Biological Sciences, University of Auckland, Auckland, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.

概括

素基因相关 (CGRP) 和 pituitary adenylate cyclase-activating polypeptide (PACAP) 的受体结合变体可能会影响偏头痛治疗. 了解这些变体可以改善抗偏头痛药物设计和患者反应.